Abbey Exits Bankrupt Argos, Takes CEO Post at Novadip Biosciences - ...

12/12/18

Abbey Exits Bankrupt Argos, Takes CEO Post at Novadip Biosciences  Xconomy

Argos Therapeutics CEO Jeff Abbey has left the company and will start a new role as chief executive of Novadip Biosciences. Argos (OTCMKTS: ]) terminated.

[more]